Quick Answer
CARLSMED, INC. reported Diluted EPS of $2.12 per share (loss) for fiscal year 2025.
CARLSMED, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.12 | +65.3% |
| 2024 | -$6.11 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.40 | +80.6% | +72.8% |
| June 30, 2025 | -$1.47 | +5.2% | +28.6% |
| September 30, 2024 | -$2.06 | — | -32.9% |
| June 30, 2024 | -$1.55 | — | — |
- CARLSMED, INC. showed an increase of +65.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, CARLSMED, INC.’s diluted eps has grown by 65.3% (from $6.11 per share (loss) to $2.12 per share (loss)).
- The most recent figure is from CARLSMED, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: